BofA Securities Resumes Acumen Pharmaceuticals, Inc. (ABOS) at Buy
Tweet
Share
E-mailGet Alerts ABOS Hot Sheet
Price: $2.54 -0.39%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham resumes coverage on Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) with a Buy rating and a price target of $14.00.
For an analyst ratings summary and ratings history on Acumen Pharmaceuticals, Inc. click here. For more ratings news on Acumen Pharmaceuticals, Inc. click here.
Shares of Acumen Pharmaceuticals, Inc. closed at $7.41 yesterday.
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Leerink Starts Ligand Pharma (LGND) at Outperform
- Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
